Drug Trial Radar · NCT07823322
A Study to Evaluate INCA33890 in the Treatment of Circulating Tumor DNA-Positive Stage II/III Microsatellite Stable Colorectal Cancer After Curative Resection and Chemotherapy
Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
40
Planned (sponsor's estimate)
Start
Dec 14, 2026
Primary completion
May 14, 2029
Study completion May 14, 2029
Sponsor
- Lead sponsor
- Incyte CorporationIncyte (INCY)
- Sponsor type
- Industry
- First posted
- Sep 16, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate INCA33890 in the treatment of circulating tumor DNA-positive stage II/III microsatellite stable colorectal cancer after curative resection and chemotherapy.
Conditions
- CRC (Colorectal Cancer)
Interventions
INCA33890Drug
INCA33890 will be administered at protocol defined dose.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Circulating tumor DNA (ctDNA) clearanceTime frame: 3 months
Locations
15 sites in 2 countries. Site status is shown where the registry gives one.
City of Hope Medical Center
Duarte, California · Not yet recruiting
Oncura Health
Glendale, California · Not yet recruiting
City of Hope Medical Center
Irvine, California · Not yet recruiting
City of Hope - Chicago Cancer Center
Zion, Illinois · Not yet recruiting
Maryland Oncology Hematology P.A.
Rockville, Maryland · Not yet recruiting
The University of North Carolina At Chapel Hill
Chapel Hill, North Carolina · Not yet recruiting
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania · Not yet recruiting
Tennessee Oncology, Pllc
Nashville, Tennessee · Not yet recruiting
Vanderbilt University Medical Center
Nashville, Tennessee · Not yet recruiting
Texas Oncology Northeast Location
Flower Mound, Texas · Not yet recruiting
Md Anderson Cancer Center
Houston, Texas · Not yet recruiting
Texas Oncology
Webster, Texas · Not yet recruiting
Virginia Cancer Specialists, Pc
Fairfax, Virginia · Not yet recruiting
Fred Hutchinson Cancer Center
Seattle, Washington · Not yet recruiting
Pan American Center For Oncology Trials, Llc
Ponce, Puerto Rico · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.